2-[4-(carboxymethoxy)phenyl]quinoline-4-carboxylic acid, 250mg

4-(Methylamino)-3-nitropyridine, 95.0%, 5g

3-Acetylphenyl ethyl(methyl)carbamate, 95.0%, 5g

2-Bromo-4-methylbenzoic acid, 98.0%, 1g

Tetrakis[?-(2S)-3,3-dimethyl-2-(phthalimido) butanoato-?O,O]dirhodium, 97%, 50mg

2-(2-Dimethylaminoethyl)pyridine, 98%, 25g

2-Chloroquinolin-7-ol, 97%, 5g

4-Methyl-5-nitro-1H-indole, 95.0%, 1g

DBD-H [=4-(N,N-Dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

5-(4-Methoxy-phenyl)-3,4-dihydro-2H-pyrrole, 95.0%, 1g

Glass vials with rolled rim Short, 30 ml, Height, 72 mm, 108 Piece(s)

N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-nitrobenzamide, 96%, 250mg

5-Bromo-3,4-dihydronaphthalen-1(2H)-one, 98.0%, 1g